- Home
- PEPG vs DDI Comparison
PEPG vs DDI Comparison
Compare PEPG & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PEPG | DDI |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 433.6M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PEPG | DDI |
|---|---|---|
| Price | $5.76 | $8.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $11.67 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 721.3K | 73.9K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.65 |
| Revenue Next Year | N/A | $2.64 |
| P/E Ratio | ★ N/A | $4.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.89 | $8.09 |
| 52 Week High | $7.80 | $11.25 |
Technical Indicators
Market Signals| Indicator | PEPG | DDI |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 51.10 |
| Support Level | $4.36 | $8.64 |
| Resistance Level | $6.81 | $9.32 |
| Average True Range (ATR) | 0.59 | 0.29 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 35.87 | 51.81 |
Price Performance
Historical ComparisonAbout PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.